Wolfgang A Weber
Consensus on molecular imaging and theranostics in prostate cancer
Fanti S, Montironi R, Ost P, O'Sullivan J, Padhani A, Schalken J, Scher H, Tombal B, van Moorselaar R, Van Poppel H, Vargas H, Walz J, Weber W, Wester H, Lecouvet F, Hicks R, Herrmann K, Minozzi S, Antoch G, Banks I, Briganti A, Carrio I, Chiti A, Clarke N, Eiber M, de Bono J, Fizazi K, Gillessen Sommer S, Gledhill S, Haberkorn U, Oyen W. Consensus on molecular imaging and theranostics in prostate cancer. Lancet Oncol 2018; 19:e696-e708.
Dec 1, 2018Consensus on molecular imaging and theranostics in prostate cancer
Dec 1, 2018Lancet Oncol 2018; 19:e696-e708
Fanti Stefano, Montironi Rodolfo, Ost Piet, O'Sullivan Joe M, Padhani Anwar R, Schalken Jack A, Scher Howard I, Tombal Bertrand, van Moorselaar R Jeroen A, Van Poppel Heindrik, Vargas Hebert Alberto, Walz Jochen, Weber Wolfgang A, Wester Hans-Jürgen, Lecouvet Frederic, Hicks Rodney J, Herrmann Ken, Minozzi Silvia, Antoch Gerald, Banks Ian, Briganti Alberto, Carrio Ignasi, Chiti Arturo, Clarke Noel, Eiber Matthias, de Bono Johann, Fizazi Karim, Gillessen Sommer Silke, Gledhill Sam, Haberkorn Uwe, Oyen Wim J G
Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1)
Oehlke O, Weber W, Meyer P, Short S, Baumert B, Mader I, Weyerbrock A, Schneider-Fuchs S, Götz I, Nestle U, Schimek-Jasch T, Graf E, Mix M, Grosu A. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1). BMC cancer 2016; 16:769.
Oct 5, 2016Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1)
Oct 5, 2016BMC cancer 2016; 16:769
Oehlke Oliver, Weber Wolfgang A, Meyer Philipp T, Short Susan C, Baumert Brigitta G, Mader Irina, Weyerbrock Astrid, Schneider-Fuchs Sabine, Götz Irina, Nestle Ursula, Schimek-Jasch Tanja, Graf Erika, Mix Michael, Grosu Anca-Ligia
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
Wild D, Ell P, Perren A, Bomanji J, Weber W, Seufert J, Brändle M, Forrer F, Kurzawinski T, Caplin M, Christ E, Reubi J. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. J Nucl Med 2011; 52:1073-8.
Jun 16, 2011Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
Jun 16, 2011J Nucl Med 2011; 52:1073-8
Wild Damian, Ell Peter J, Perren Aurel, Bomanji Jamshed, Weber Wolfgang A, Seufert Jochen, Brändle Michael, Forrer Flavio, Kurzawinski Tom R, Caplin Martyn E, Christ Emanuel, Reubi Jean Claude